| 8 | 1/1 | 返回列表 |
| 查看: 976 | 回復: 7 | ||
| 本帖產(chǎn)生 1 個 翻譯EPI ,點擊這里進行查看 | ||
NearSecond金蟲 (正式寫手)
|
[求助]
求助摘要翻譯
|
|
|
An asymmetric synthesis of substituted piperidines has been described.b-Cyclodextrin- or oxazaborolidine-catalyzed asymmetric reduction ofa-azido aryl ketones to the corresponding alcohols has been employed as the key step along with ring closing metathesis and selective dihydroxylation. Substituted piperidines (polyhydroxy piperidines or azasu-gars) have been identified as an important class of therapeu-tic agents in the treatment of influenza infection,1cancermetastatis,2viral infections including AIDS,3and diabetes(Fig. 1).4As a result, numerous classes of inhibitors havebeen developed, some of which provide interesting insights into the mechanism of enzymatic glycoside hydrolysis.Amongst them, both naturally occurring and syntheticpolyhydroxylated piperidines5(1–4) have been shown tobe specific and potent inhibitors of glycosidases6and have been demonstrated to have great potential as drugs for treating a variety of carbohydrate mediated diseases.7 As a consequence of this, there has been a great deal of interest, not only in the synthesis of the natural products themselves, but also that of chemically modified analogues. However, most of the methodologies have been developed for the synthesis of compounds 1and4and their stereo-isomers,8,9which can be regarded as substituted piperidines,starting from the carbohydrates and, in general, require chiral starting materials to reach the specific target. Thus the development of new methods from achiral precursors for the enantioselective synthesis of polyhydroxylated piper-idines constitutes an area of current interest.10 Herein, we wish to report the complete asymmetric synthesis of1and4starting from readily available achiral 4-methyl phenacyl bromide5. |
金蟲 (正式寫手)

金蟲 (正式寫手)
|
我們已經(jīng)描述過不對稱合成的取代哌啶的方法.b-環(huán)糊精或惡唑硼烷催化的不對稱還原OFA-疊氮芳基酮為相應的醇已經(jīng)被證明為關(guān)鍵步驟,伴隨著閉環(huán)復分解反應和選擇性雙羥基化反應。 取代的哌啶(羥基哌啶或)已被確定為在在流感病毒感染、轉(zhuǎn)移癌、病毒感染包括艾滋病在內(nèi)和糖尿病(圖1)的一類重要的治療藥物,因此,很多抑制劑都被開發(fā)了,其中一些在對酶促糖苷水解反應機制上產(chǎn)生很大興趣.在這些藥物當中,無論是天然存在的還是合成的多羥基哌啶都已展示出明確的作用效果是很強的糖苷酶抑制劑,并被證明有很大的潛力成為治療多種碳水化合物介導的疾病的藥物。 因此,不僅在合成的天然化合物本身,在化學修飾的類似物合成上也具有極大的興趣。然而,大多數(shù)已被開發(fā)的方法都是用來合成被稱為取代哌啶的化合物1和4and它們的立體異構(gòu)體8和9,它們從碳水化合物開始并在一般情況中,需要手性起始物來達到的特定目的。因此,從非手性前體物質(zhì)具有立體選擇性的合成多羥基哌啶事當前我們應當發(fā)展的方向.在此,我們希望報導出從容易獲得的非手性4 - 甲基苯甲酰溴化物來不對稱合成化合物1和4的方法。 |

新蟲 (初入文壇)
|
取代的哌啶的不對稱合成已經(jīng)described.b-cyclodextrin或惡唑硼烷催化的不對稱還原一個疊氮基芳基酮為相應的醇已被作為關(guān)鍵步隨著關(guān)環(huán)復分解反應和選擇性羥化。 取代的哌啶(多羥基哌啶或azasu雀鱔)已被確定為一類重要的藥物治療抽動在流感病毒感染,治療1cancermetastatis 2viral感染,包括艾滋病,和糖尿。▓D1)4。結(jié)果,許多類抑制劑被開發(fā),其中一些提供酶糖苷水解機理的有趣的見解。其中,自然發(fā)生和syntheticpolyhydroxylated piperidines5(1–4)已被證明是具體和有效的抑制劑glycosidases6and已被證明有很大的潛力,作為藥物治療多種碳水化合物介導的疾病。7 因此,有極大的興趣,不僅在天然產(chǎn)物合成自己,而且,化學改性的類似物。然而,大多數(shù)的方法已被開發(fā)用于化合物的合成1and4and其立體異構(gòu)體,8,9which可以被視為取代的哌啶,從碳水化合物,在一般情況下,要求 手性原料達到特定的目標。從而為多羥基Piper idines的不對稱合成手性前體的新方法的發(fā)展是當前interest.10面積外,我們 要報告的完整的不對稱合成的手性4-甲基苯甲酰甲基of1and4starting現(xiàn)成bromide5。 |
| 8 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 340求調(diào)劑 +5 | jhx777 2026-03-27 | 5/250 |
|
|---|---|---|---|---|
|
[考研] 291求調(diào)劑 +13 | hhhhxn.. 2026-03-23 | 19/950 |
|
|
[考研] 085600 286分 材料求調(diào)劑 +4 | 麻辣魷魚 2026-03-27 | 5/250 |
|
|
[考研] 352分 化工與材料 +5 | 海納百川Ly 2026-03-27 | 5/250 |
|
|
[考研] 張芳銘-中國農(nóng)業(yè)大學-環(huán)境工程專碩-298 +3 | 手機用戶 2026-03-26 | 3/150 |
|
|
[考研] 0703化學 +6 | 妮妮ninicgb 2026-03-27 | 6/300 |
|
|
[考研] 0703一志愿9,初試成績:338,四六級已過,有科研經(jīng)歷,求調(diào)劑! +3 | Zuhui0306 2026-03-25 | 3/150 |
|
|
[考研] 315調(diào)劑 +4 | 0860求調(diào)劑 2026-03-26 | 5/250 |
|
|
[考研] 314求調(diào)劑 +3 | 溪云珂 2026-03-26 | 3/150 |
|
|
[考研] 調(diào)劑推薦 +5 | 清酒714 2026-03-26 | 6/300 |
|
|
[考研] 考研調(diào)劑 +9 | 小蠟新筆 2026-03-26 | 9/450 |
|
|
[碩博家園] 北京林業(yè)大學碩導招生廣告 +6 | kongweilin 2026-03-26 | 8/400 |
|
|
[考研] 342求調(diào)劑 +3 | 加油a李zs 2026-03-26 | 3/150 |
|
|
[考研] 285求調(diào)劑 +3 | AZMK 2026-03-24 | 3/150 |
|
|
[考研] 293求調(diào)劑 +7 | 加一一九 2026-03-24 | 7/350 |
|
|
[考研] 086003食品工程求調(diào)劑 +6 | 淼淼111 2026-03-24 | 6/300 |
|
|
[論文投稿] 急發(fā)核心期刊論文 +3 | 賢達問津 2026-03-23 | 5/250 |
|
|
[考研] 280分求調(diào)劑 一志愿085802 +4 | PUMPT 2026-03-22 | 7/350 |
|
|
[考研] 315分,誠求調(diào)劑,材料與化工085600 +3 | 13756423260 2026-03-22 | 3/150 |
|
|
[考研] 考研調(diào)劑 +3 | 呼呼?~+123456 2026-03-21 | 3/150 |
|